CSBR:NASDAQ
Champions Oncology Inc
US$4,34
arrow_downward
-1,36%(-0,060) 1D
20 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,45
High
US$4,45
Low
US$4,34
Mkt. cap
60,41 ລ້ານ
Avg. vol.
6,97 ພັນ
Volume
8,94 ພັນ
52-wk high
US$8,31
52-wk low
US$4,34
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,45
High
US$4,45
Low
US$4,34
Mkt. cap
60,41 ລ້ານ
Avg. vol.
6,97 ພັນ
Volume
8,94 ພັນ
52-wk high
US$8,31
52-wk low
US$4,34
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
24/7 Wall St.
·
19 ນາທີກ່ອນ
The S&P 500 Is Now Below Every Wall Street Year-End Target for 2026
Beinsure
·
3 ຊົ່ວໂມງກ່ອນ
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
The Motley Fool
·
2 ຊົ່ວໂມງກ່ອນ
The S&P 500 Heads Into Thanksgiving Below Its Peak. Here's How the Holiday Week Has Usually Gone Since 1950.
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com